Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study

2021610 citationsJournal Articlehybrid Open Access

Authors

King's College London, Cancer Research UK, Wellcome Trust, Rosetrees Trust, and Francis Crick Institute.

Good health and well-being

Published in: The Lancet Oncology

Volume 22, Issue 6, pp. 765-778

Field-Weighted Citation Impact: 37.92